Concepedia

Judith A. Veitch

JA

Statistics

Publications

5

Citations

155

H-Index

5

Active since

1989

Affiliations

Bristol-Myers Squibb (United States)(Current)

Judith A. Veitch is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1989–1997

5

Publications

5

Biosynthesis of esperamicin A1, an enediyne antitumor antibiotic

Kin S. Lam, Judith A. Veitch, Jerzy Golik et al. · Journal of the American Chemical Society · 1993 · 55 citations

, , +20

BMS-182123, a Fungal Metabolite that Inhibits the Production of TNF-.ALPHA. by Macrophages and Monocytes.

Glenn A. Warr, Judith A. Veitch, Ann W. Walsh et al. · The Journal of Antibiotics · 1996 · 51 citations

Bripiodionen, a New Inhibitor of Human Cytomegalovirus Protease from <i>Streptomyces</i> sp. WC76599

Yue‐Zhong Shu, Qingmei Ye, Janet M. Kolb et al. · Journal of Natural Products · 1997 · 20 citations

, , +17

The effect of cerulenin on the production of esperamicin A1 byActinomadura verrucosospora

Kin S. Lam, DONALD R. GUSTAVSON, Judith A. Veitch et al. · Journal of Industrial Microbiology & Biotechnology · 1993 · 17 citations · Full text

Biosynthesis of Elsamicin A, a Novel Antitumor Antibiotic

Kin S. Lam, Judith A. Veitch, Salvatore Forenza et al. · Journal of Natural Products · 1989 · 12 citations

1–5 of 5